Position in STTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$496,536
+$296,165 QoQ
Shares Held
71,547
+129.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 100 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. STTK ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | 290,713 | $38,586,336 | |||
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in STTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,536 | 71,547 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $200,371 | 31,162 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $236,465 | 64,785 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $46,031 | 19,260 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $185,183 | 47,975 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $521,577 | 58,342 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $42,556 | 13,640 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,490 | 10,371 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | $281,195 | 33,043 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||